# Ginsenoside-Rd for Acute Ischemic Stroke

> **NCT00591084** · PHASE2 · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 199 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** ginsenoside-Rd 10 mg
- **DRUG:** placebo
- **DRUG:** ginsenoside-Rd 20mg

## Key facts

- **NCT ID:** NCT00591084
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-06
- **Final completion:** 2006-09
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2010-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00591084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00591084, "Ginsenoside-Rd for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00591084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*